REVOLUTIONARY PANEL TESTING

Our multiplex testing is a mind shift in diagnostic testing; it negates reflex testing saving time and money. Advances in genomic research have provided hardcore evidence revealing multiple mutations associated with more than one gene as the cause of specific genetic disease or cancer.
This current knowledge was possible via whole genome studies and has challenged the traditional concept of health and disease. This has resulted in the development of choice tests panels for specific diseases and has facilitated the paradigm shift towards personalized medicine.
Data has proven this concept to be important in infectious disease process due to the fact a reasonable percentage of infections are caused by multiple agents and has led to development of infectious disease panel tests for CNS infections, Respiratory infections and STIs.

Details of our panel testing

STI panel test for these 10 targets:

  • Neisseria gonorrhoea (NG)
  • Chlamydia trachomatis (CT)
  • Trichomonas vaginalis (TV)
  • Treponema pallidum (TP)
  • Herpes simplex Virus 1 (HSV-1)
  • Herpes simplex Virus 2 (HSV-2)
  • Mycoplasma genitalium (MG)
  • Ureaplasma urealyticum (UU)
  • Haemophilus ducreyi (HD)
  • Mycoplasma hominis (MH)

Respiratory panel test for these 22 targets:

Viral:
  • Human Respiratory Syncytial Virus A
  • Bordetella pertussis
  • Chlamydophila pneumoniae
  • Mycoplasma pneumoniae
  • Legionella Pneumophila
  • Moraxella Catarrhalis
  • Streptococcus Pneumoniae
  • Haemophilus Influenza
Bacterial:
  • Human Respiratory Syncytial Virus b
  • Human Parainfluenza Virus 1/2/3/4
  • Human Coronavirus 229E/NL63
  • Human Coronavirus OC43/HKU1
  • Human Metapneumovirus
  • Human Rhinovirus A/B
  • Human Enterovirus A/B/C
  • Human Adenovirus A/B/C/D/E
  • Human Bocavirus 1/2/3
  • Influenza A/B

Cancer panel

This panel simultaneously tests for 20 mutations with 3 genes: K-RAS, BRAF and PI3Kca which are the cause of many cancers including colo-rectal, thyroid, malignant melanoma and others. In addition the panel helps in prognostication and better choice of treatment.
KRAS (Codon 12, 13, 61, 146) BRAF (600) PIK3Ca (542, 545, 1047)